SE9900398L - Ny användning inom transplantationskirurgi - Google Patents

Ny användning inom transplantationskirurgi

Info

Publication number
SE9900398L
SE9900398L SE9900398A SE9900398A SE9900398L SE 9900398 L SE9900398 L SE 9900398L SE 9900398 A SE9900398 A SE 9900398A SE 9900398 A SE9900398 A SE 9900398A SE 9900398 L SE9900398 L SE 9900398L
Authority
SE
Sweden
Prior art keywords
transplantation
new use
transplant surgery
present
islets
Prior art date
Application number
SE9900398A
Other languages
Unknown language ( )
English (en)
Other versions
SE523817C2 (sv
SE9900398D0 (sv
Inventor
Olle Korsgren
William Bennet
Bo Nilsson
Rolf Larsson
Original Assignee
Corline Systems Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corline Systems Ab filed Critical Corline Systems Ab
Priority to SE9900398A priority Critical patent/SE523817C2/sv
Publication of SE9900398D0 publication Critical patent/SE9900398D0/sv
Priority to EP00906843A priority patent/EP1171156B1/en
Priority to DE60032346T priority patent/DE60032346T2/de
Priority to AU28399/00A priority patent/AU769063B2/en
Priority to CA2361949A priority patent/CA2361949C/en
Priority to PCT/SE2000/000223 priority patent/WO2000045837A1/en
Priority to AT00906843T priority patent/ATE348149T1/de
Priority to US09/890,936 priority patent/US7981873B1/en
Priority to JP2000596956A priority patent/JP2003501346A/ja
Publication of SE9900398L publication Critical patent/SE9900398L/sv
Publication of SE523817C2 publication Critical patent/SE523817C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9900398A 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler SE523817C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler
JP2000596956A JP2003501346A (ja) 1999-02-05 2000-02-04 移植手術における新規な使用
CA2361949A CA2361949C (en) 1999-02-05 2000-02-04 Heparin, or heparin conjugate, islets of langerhans
DE60032346T DE60032346T2 (de) 1999-02-05 2000-02-04 Neue Verwendung in der Transplantationsschirugie
AU28399/00A AU769063B2 (en) 1999-02-05 2000-02-04 Novel use within transplantation surgery
EP00906843A EP1171156B1 (en) 1999-02-05 2000-02-04 Isolierte inslen, die insulin-produzierende zellen enthalten, beschichtete mit heparin
PCT/SE2000/000223 WO2000045837A1 (en) 1999-02-05 2000-02-04 Novel use within transplantation surgery
AT00906843T ATE348149T1 (de) 1999-02-05 2000-02-04 Isolated islets, comprising insulin producing cells, coated with heparin
US09/890,936 US7981873B1 (en) 1999-02-05 2000-02-04 Use within transplantation surgery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler

Publications (3)

Publication Number Publication Date
SE9900398D0 SE9900398D0 (sv) 1999-02-05
SE9900398L true SE9900398L (sv) 2000-08-06
SE523817C2 SE523817C2 (sv) 2004-05-18

Family

ID=20414376

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler

Country Status (9)

Country Link
US (1) US7981873B1 (sv)
EP (1) EP1171156B1 (sv)
JP (1) JP2003501346A (sv)
AT (1) ATE348149T1 (sv)
AU (1) AU769063B2 (sv)
CA (1) CA2361949C (sv)
DE (1) DE60032346T2 (sv)
SE (1) SE523817C2 (sv)
WO (1) WO2000045837A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200198D0 (sv) 2002-01-23 2002-01-23 Astrazeneca Ab New use
ES2402096T3 (es) * 2003-03-26 2013-04-26 Evotec International Gmbh Uso de proteínas relacionadas con saposina para prevenir y tratar la obesidad, diabetes y/o síndrome metabólico
WO2007004975A1 (en) * 2005-07-01 2007-01-11 Corline Systems Ab Heparin coating of biological tissue
SE530716C2 (sv) * 2006-10-06 2008-08-19 Corline Systems Ab Molekylärt aggregat på ett substrat
WO2011109877A1 (en) * 2010-03-12 2011-09-15 The Australian National University Heparan sulfate replacement therapy
US9795629B2 (en) 2011-12-22 2017-10-24 Corline Systems Ab Aqueous solution comprising a macromolecular conjugate of heparin for the treatment of blood vessels
WO2017149391A1 (en) * 2016-03-02 2017-09-08 Laboratoire Francais Du Fractionnement Et Des Biotechnologies The use of antithrombin for coating organs during transplantation
CN120957766A (zh) 2023-03-30 2025-11-14 科林生物医学公司 肝素官能化表面及其制备和用途
CN121038826A (zh) 2023-03-30 2025-11-28 科林生物医学公司 用于提供改进的肝素功能化表面的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135916A (en) 1989-06-12 1992-08-04 Oklahoma Medical Research Foundation Inhibition of complement mediated inflammatory response
MY107433A (en) 1989-10-12 1995-12-30 Imutran Ltd Modiefied biological material.
SE470006B (sv) 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
WO1993009176A2 (en) * 1991-10-29 1993-05-13 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
DE69334033D1 (de) 1992-05-21 2006-07-27 Diatide Inc Technetium-99M markierte Peptide zur Bilderzeugung von Thrombus
WO1997011607A1 (en) 1995-09-27 1997-04-03 Emory University Method of inhibiting immune system destruction of transplanted viable cells
DE19623440A1 (de) * 1996-06-12 1997-12-18 Wagner Karl Heinz Dr Med Immobilisiertes organisches Material mit definiertem Wirkstoff-Release
ES2513043T3 (es) 1997-03-26 2014-10-24 Imperial Innovations Limited Proteína de fusión anticoagulante anclada a membrana de la célula

Also Published As

Publication number Publication date
CA2361949C (en) 2010-08-03
EP1171156B1 (en) 2006-12-13
US7981873B1 (en) 2011-07-19
SE523817C2 (sv) 2004-05-18
EP1171156A1 (en) 2002-01-16
AU769063B2 (en) 2004-01-15
AU2839900A (en) 2000-08-25
CA2361949A1 (en) 2000-08-10
WO2000045837A1 (en) 2000-08-10
DE60032346D1 (en) 2007-01-25
JP2003501346A (ja) 2003-01-14
DE60032346T2 (de) 2007-07-19
ATE348149T1 (de) 2007-01-15
SE9900398D0 (sv) 1999-02-05

Similar Documents

Publication Publication Date Title
RU2490250C2 (ru) Спиросоединения и их фармацевтическое применение
WO2009023718A3 (en) Novel activators of glucokinase
CN105979975A (zh) 医疗敷料
EP1803710A4 (en) PYRIMIDINE DERIVATIVES CONCENTRATED TO A NON-AROMATIC RING
Liang et al. Lipid rescue of massive verapamil overdose: a case report
EP1454641A3 (en) Porous implantable medical device seeded with mammalian cells
SE9900398D0 (sv) Novel use within transplantation surgery
EP2762480A1 (en) Oxazolidinone antibiotics containing fused ring
RU2009110273A (ru) Способ уменьшения повреждения нервных клеток
ATE290396T1 (de) Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament
WO2005103687A3 (en) System and method for providing optimal concentrations for medication infusions
BR0306798A (pt) Uso de melagatran ou de um derivado farmaceuticamente aceitável deste, métodos de tratamento de diabetes mellitus tipo i, de transplante de células de enxertamento de ilhotas de langerhans, para melhorar a independência de insulina em pacientes com diabetes mellitus tipo i, e de tratamento de reação inflamatória mediada pelo sangue instantânea, formulação farmacêutica para uso no tratamento de diabetes mellitus tipo i, kit de partes, e, método de fabricação de um kit de partes.
Orban et al. Erythromycin-induced cardiac toxicity
Green et al. Effectiveness of octreotide in a case of refractory sulfonylurea-induced hypoglycemia
CA2593171A1 (en) Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases
TR200200250T2 (tr) Glukoz alma agonistleri olarak yeni naftilsülfonik asitler, ilgili bileşikler
EA199900510A1 (ru) Инъекционное лекарственное средство "цитофлавин", обладающее цитопротекторным действием
CN101804211A (zh) 恒河猴自身免疫性1型糖尿病模型的建立
CO5611170A2 (es) Uso de un inhibidor antagonista contra el factor tisular
CN112209834B (zh) 一种有机亚硝酸根供体及其制备方法与医药用途
KR101823205B1 (ko) 약물을 봉입한 이식 치료용 세포 클러스터 및 이의 제조방법
KR20080061431A (ko) 에이디피-라이보실 사이클레이즈 억제제를 이용한 고혈압 및 당뇨병성 신증의 치료제
JP2022543699A5 (sv)
NO20061515L (no) Anvendelse av okskarbazepin for behandling av diabetisk neurpatisk smerte og forbedring av sovn
CN101474178A (zh) 盐酸戊乙奎醚在制备治疗心源性休克疾病药物中的应用

Legal Events

Date Code Title Description
NUG Patent has lapsed